-

BioTek reMEDys Shines a Spotlight on Pharmacists for National Pharmacy Week

Specialty Infusion Pharmacy Company Promotes Awareness and Education of Safe Medication Use

NEW CASTLE, Del.--(BUSINESS WIRE)--In honor of National Pharmacy Week earlier this month, BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, staged a series of spirited company-wide events and activities to celebrate the critical role pharmacists play in healthcare.

“Pharmacy Strong” was the theme of this year’s National Pharmacy Week, designed to recognize the dedication and resilience of the pharmacy workforce in these unprecedented times.

“Pharmacy Week is a time to recognize the powerful impact pharmacists make on patients. It is also an opportunity to raise patients' and colleagues' awareness about the vital role pharmacists play on the healthcare team,” said BioTek reMEDys’ CEO and founder Chaitanya Gadde. “For us, of course, every week is Pharmacy Week, but we embrace the concept of shining a national spotlight on these essential professionals. As a pharmacist-founded organization that works alongside pharmacy and specialty pharmacy professionals every day, we are keenly aware of the essential role these experts play on the healthcare team and we are passionate about acknowledging their efforts to ensure medication use is safe and patients are achieving optimal outcomes.”

“We are proud to work alongside pharmacy professionals and colleagues as well as the pharmacists at health plans and pharmacy benefit managers, and as we serve the highly specific needs of patients through our specialty infusion services,” added Gadde. “The theme of Pharmacy Strong resonates throughout BioTek and we applaud the tireless efforts of pharmacists and specialty pharmacists year round.”

BioTek reMEDys provides therapy-specific patient education materials and its National Customer Support Center is available 24 hours a day, seven days a week to help patients and their loved ones manage critical aspects of care. By servicing very specific disease states, BioTek reMEDys’ expert team can maintain its focus on patient care – making sure that dosages and treatments are appropriate.

BioTek reMEDys is a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases. Through supply chain management, innovative technology and trained specialty pharmacists, BioTek reMEDys is able to deliver superior service at a lower cost. The company bridges the gap between managed care, physicians and patients by facilitating the authorization, procurement and administration of specialty medications and infusions. BioTek reMEDys provides high-touch therapies, biologics and pharmaceuticals to support treatment for patients with rare diseases and chronic conditions, ensuring the highest quality of care. For information visit www.biotekrx.com.

Contacts

Paul Williams
paul@medialinecommunications.com
310/569-0023

BioTek reMEDys


Release Versions

Contacts

Paul Williams
paul@medialinecommunications.com
310/569-0023

Social Media Profiles
More News From BioTek reMEDys

BioTek reMEDys Encourages Education and Awareness for Autoinflammatory Conditions

NEW CASTLE, Del.--(BUSINESS WIRE)--BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for year-round enhanced education and awareness of these rare diseases and conditions. Autoinflammatory diseases refer to problems with the innate immune system’s reactions. Immune cells target the body’s own healthy tissues by mistake, signaling the body to attack them. This can cause intense episodes of inf...

BioTek reMEDys Celebrates the Work of Collaborating Healthcare Professionals During National Interprofessional Healthcare Month

NEW CASTLE, Del.--(BUSINESS WIRE)--In recognition of National Interprofessional Healthcare Month, BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for awareness of safe medication use for patients with rare diseases and conditions, while celebrating the critical contributions and collaborative spirit of healthcare professionals nationwide, applauding the efforts of those who impact the patie...

BioTek reMEDys Names Neal Fitzpatrick Chief Strategy Officer

NEW CASTLE, Del.--(BUSINESS WIRE)--BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, has named Neal C. Fitzpatrick as its Chief Strategy Officer. Fitzpatrick recently served as Chief Commercial Officer at a biotech company, charged with leading the organization through a period of high growth. Before this, he served as Vice-President of Sales at ADMA Biologics, where he repositioned an essential product from hos...
Back to Newsroom